First Manhattan
HARP

First Manhattan’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

First Manhattan’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed – – 1810
2022
Q3 		$0 Hold
7
– – ﹤0.01% 1698
2022
Q2 		$0 Hold
7
– – ﹤0.01% 1704
2022
Q1 		$0 Hold
7
– – ﹤0.01% 1720
2021
Q4 		$0 Hold
7
– – ﹤0.01% 1716
2021
Q3 		$0 Hold
7
– – ﹤0.01% 1711
2021
Q2 		$0 Hold
7
– – ﹤0.01% 1645
2021
Q1 		$1K Hold
7
– – ﹤0.01% 1455
2020
Q4 		$1K Hold
7
– – ﹤0.01% 1319
2020
Q3 		$1K Hold
7
– – ﹤0.01% 1306
2020
Q2 		$1K Hold
7
– – ﹤0.01% 1363
2020
Q1 		$0 Buy
+7
New +$984 ﹤0.01% 1487

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

First Manhattan's HARP Position: Q4 2022 in Review

First Manhattan sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 7 shares.

First Manhattan first reported a position in HARP in Q1 2020 and held it in 11 quarters. The position peaked at $1K in Q1 2021. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • First Manhattan reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • First Manhattan sold 7 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022.
  • First Manhattan first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • First Manhattan's Harpoon Therapeutics, Inc. Common Stock position peaked at $1K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.